4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸(641569-94-0)名称与标识符
名称
中文别名:
4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸;4-甲基-3-[[4-(3-吡啶-4-甲基)-2-嘧啶基]氨基]苯甲酸;尼罗替尼中间体1;尼罗替尼中间体2;尼罗替尼中间体4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸;4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)苯甲酸;尼洛替尼中间体2;
英文别名:
4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid;4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzoic acid;4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid;4-METHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-BENZOIC ACID;4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid);Benzoic acid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-;Temsirolimus;3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylbenzoic acid;4-methyl-3-(4-(pyridine-3-yl)pyrimidin-2-ylamino)benzoic acid;4-methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]benzoic acid;4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzoic acid;BEN74;Benzoic acid,4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino];TQ9WCS4PF0;4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzoic acid;4-Methyl-3-((4-(3-pyridyl)pyrimidin-2-yl)amino)benzoic acid;4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]benzoic acid;4-methyl;PS-7101;4-(5-amino-6-hydroxy-2-benzoxazolyl)-benzoicacid;641569-94-0;AC-8510;MFCD11521324;BCP04528;Benzoic acid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-; 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid; Nilotinib Hydrochloride Monohydrate Impurity D; Nilotinib Impurity D;LDLZPHLSVKGFSC-UHFFFAOYSA-N;NILOTINIB HYDROCHLORIDE MONOHYDRATE IMPURITY D [EP IMPURITY];A8804;SY107567;UNII-TQ9WCS4PF0;Nilotinib hydrochloride monohydrate impurity D [EP];DTXSID90439380;AKOS015888621;Benzoic acid, 4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-;CS-0009198;Q-101350;C17H14N4O2;FT-0655847;4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoicacid;AM20090654;4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoic Acid;4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)benzoic acid;4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoic acid;SB57892;SCHEMBL533540;NILOTINIB HYDROCHLORIDE MONOHYDRATE IMPURITY D (EP IMPURITY);Nilotinib hydrochloride monohydrate impurity D;
标识符
InChIKey:
LDLZPHLSVKGFSC-UHFFFAOYSA-N
Inchi:
1S/C17H14N4O2/c1-11-4-5-12(16(22)23)9-15(11)21-17-19-8-6-14(20-17)13-3-2-7-18-10-13/h2-10H,1H3,(H,22,23)(H,19,20,21)
SMILES:
OC(C1C=CC(C)=C(C=1)NC1N=CC=C(C2C=NC=CC=2)N=1)=O